Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $3.9 million.

  • Celularity's Cost of Revenue rose 54.08% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 1615.76%. This contributed to the annual value of $15.0 million for FY2024, which is 641.23% down from last year.
  • Celularity's Cost of Revenue amounted to $3.9 million in Q3 2025, which was up 54.08% from $5.2 million recorded in Q2 2025.
  • Celularity's Cost of Revenue's 5-year high stood at $9.6 million during Q4 2023, with a 5-year trough of $724000.0 in Q1 2021.
  • For the 5-year period, Celularity's Cost of Revenue averaged around $3.2 million, with its median value being $2.6 million (2022).
  • In the last 5 years, Celularity's Cost of Revenue surged by 49609.97% in 2022 and then crashed by 4613.83% in 2023.
  • Over the past 5 years, Celularity's Cost of Revenue (Quarter) stood at $1.4 million in 2021, then surged by 192.17% to $4.2 million in 2022, then soared by 129.83% to $9.6 million in 2023, then dropped by 23.58% to $7.3 million in 2024, then tumbled by 46.83% to $3.9 million in 2025.
  • Its Cost of Revenue was $3.9 million in Q3 2025, compared to $5.2 million in Q2 2025 and $3.6 million in Q1 2025.